PDF(Sci-hub)
Abstract：
A 61-year-old woman with a history of palpebral conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma, treated with rituximab, was referred to the authors\' hospital after follow-up positron emission tomography/computed tomography revealed 18F-fluoro-2-deoxy-d-glucose uptake in a tumor located in the left main bronchus. The diagnosis of MALT lymphoma was made by pathological and immunohistochemical findings homologous to previous palpebral conjunctival lesion via bronchoscopic biopsy. The disease was controlled with rituximab, cyclophosphamide, oncovin, and prednisolone (i.e., R-COP) chemotherapy. Although MALT lymphoma occurs in several organs, metachronous occurrence in the palpebral conjunctiva and bronchus is especially rare, and careful check-up is required to monitor for occurrence of systemic relapse.
摘要：
一名61岁的女性，有睑结膜粘膜相关淋巴组织（MALT）淋巴瘤的病史，用利妥昔单抗治疗，在随访正电子发射断层扫描/计算机断层扫描显示位于左主支气管的肿瘤中摄取18F-氟-2-脱氧-d-葡萄糖后，被转诊至作者的医院。MALT淋巴瘤的诊断是通过支气管镜活检与先前的睑结膜病变同源的病理和免疫组织化学结果。利妥昔单抗控制了病情,环磷酰胺,oncovin,和泼尼松龙(即，R-COP)化疗。虽然MALT淋巴瘤发生在几个器官中，眼睑结膜和支气管的异时发生尤其罕见，并且需要仔细检查以监测全身复发的发生。
